Mylan Barred From Selling Generic Oracea
A federal judge has approved dermatology company Galderma Laboratories Inc.'s bid for a preliminary injunction preventing Mylan Pharmaceuticals Inc. from selling a generic version of rosacea drug Oracea....To view the full article, register now.
Already a subscriber? Click here to view full article